Showing results (411-420 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|June 26, 2018
Feasibility and Efficacy of High-Dose Chemotherapy and Autologous Hematopoietic Cell Transplantation for HIV-Associated Lymphoma: A Single-Institution ExperienceErnesto Ayala, Julio C Chavez, Alexandra Gomez, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 26, 2018
Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium AnalysisYazan Migdady, John Barnard, Najla Al Ali, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 23, 2019
Clinical Experience With Ibrutinib Alone or in Combination With Either Cytarabine or Azacitidine in Patients With Acute Myeloid LeukemiaJorge E Cortes, Brian A Jonas, Thorsten Graef, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 16, 2019
The Outcomes of Chronic Myeloid Leukemia Patients With Molecular Warning Responses During Imatinib Treatment According to the European LeukemiaNet 2013 RecommendationsTeoman Soysal, Ahmet Emre Eskazan, Istemi Serin, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 3, 2019
Prevalence and Effect on Survival of Pulmonary Hypertension in MyelofibrosisMatthew Austin, Peter J Quesenberry, Corey E Ventetuolo, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 20, 2021
Refractory DLBCL: Challenges and TreatmentMendel Goldfinger, Dennis L Cooper
Clinical Lymphoma, Myeloma & Leukemia|July 9, 2019
Blastic Plasmacytoid Dendritic Cell Neoplasm-Current InsightsSangeetha Venugopal, Selena Zhou, Siraj M El Jamal, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 7, 2021
Epidemiology of Food Insecurity in a Nationally Representative Sample of Lymphoma PatientsTaral Jella, Thomas B Cwalina, Mehdi Hamadani
Clinical Lymphoma, Myeloma & Leukemia|October 22, 2021
Injectable Hypomethylating Agents for Management of Myelodysplastic Syndromes: Patients' Perspectives on TreatmentAmer M Zeidan, Sayeli Jayade, Jordana Schmier, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 23, 2021
Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III StudyLarry W Kwak, Juan-Manuel Sancho, Seok-Goo Cho, et al.
Pageof 251